Please complete the CAPTCHA to continue
@lyratx.com
✓
2 phones found area 908 and 857
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Allison Nance is listed as Senior Vice President, Regulatory Affairs at Lyra Therapeutics at Lyra Therapeutics, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at lyratx.com, phone signal with area code 908, 857, and a matched LinkedIn profile for Allison Nance.
Allison Nance previously worked as Senior Vice President, Regulatory Affairs at Lyra Therapeutics and Senior Vice President, Regulatory Affairs & Quality Assurance at Jounce Therapeutics, Inc.. Allison Nance holds Master Of Science, Biotechnology from Johns Hopkins University Advanced Academic Programs.
This section adds company-level context without repeating Allison Nance's masked contact details.
AeroLeads found 1 current-domain work email signal for Allison Nance. Compare company email patterns before reaching out.
Allison Nance is a Senior Vice President, Regulatory Affairs at Lyra Therapeutics at Lyra Therapeutics. She possess expertise in oncology, pharmaceutical industry, biotechnology, regulatory affairs, drug discovery and 15 more skills. Colleagues describe her as "Allison has been a critical member of both the Clinical Development and Regulatory Affairs leadership and the management team at Jounce. I can't imagine the last 6+ years without her strategic input and guidance. She is a highly experienced regulatory affairs leader who led very large groups at prior companies but was willing to be the sole regulatory affairs and quality assurance person at first and then maintain a very hands on approach even after she built her group at Jounce. She will be an incredible addition to any company, as head of regulatory and QA, a member of the management team, or as a Board member. I give her my highest recommendation and will miss her terribly!"
Listed skills include Oncology, Pharmaceutical Industry, Biotechnology, Regulatory Affairs, and 16 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Watertown, Massachusetts, Us
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities.
Cambridge, Ma, Us
Our approach to cancer immunotherapy prioritizes targets and identifies related biomarkers to match the right immunotherapy to the right patients – for meaningful and long-lasting benefit.
Summit, New Jersey, Us
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company’s Web site at www.celgene.com.
Chicago, Us
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
Switzerland 🇨🇭 , Ch
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80’000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.
Deerfield, Illinois, Us
Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2010 sales of $12.8 billion and has approximately 47,600 employees.BioScience2010 Sales-$5.7 BillionBaxter Bioscience is a leading manufacturer of recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines.
Quick answers generated from the profile data available on this page.
Allison Nance works for Lyra Therapeutics.
Allison Nance is listed as Senior Vice President, Regulatory Affairs at Lyra Therapeutics at Lyra Therapeutics.
AeroLeads has found 1 work email signal at @lyratx.com for Allison Nance at Lyra Therapeutics.
AeroLeads has found 2 phone signal(s) with area code 908, 857 for Allison Nance at Lyra Therapeutics.
Allison Nance is based in Cambridge, Massachusetts, United States while working with Lyra Therapeutics.
Allison Nance has worked for Lyra Therapeutics, Jounce Therapeutics, Inc., Celgene Corporation, Ge Healthcare, and Hoffmann-La Roche.
You can use AeroLeads to view verified contact signals for Allison Nance at Lyra Therapeutics, including work email, phone, and LinkedIn data when available.
Allison Nance holds Master Of Science, Biotechnology from Johns Hopkins University Advanced Academic Programs.
Allison Nance is listed with skills including Oncology, Pharmaceutical Industry, Biotechnology, Regulatory Affairs, Drug Discovery, Regulatory Submissions, Clinical Development, and Clinical Trials.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts